Recent advances in molecular gynaecological pathology

Charles Simon Herrington

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

This review gives an overview of recent advances in our understanding of the molecular basis of gynaecological malignancy, including cervical, vulval, endometrial and ovarian tumours. These advances are beginning to influence clinical practice, perhaps most notably with the introduction of human papillomavirus vaccination for the prevention of anogenital neoplasia, but are likely to have broader clinical implications as further details emerge.

Original languageEnglish
Pages (from-to)243-249
Number of pages7
JournalHistopathology
Volume55
Issue number3
DOIs
Publication statusPublished - Sept 2009

Keywords

  • cervix
  • endometrium
  • gynaecology
  • molecular
  • ovary
  • pathology
  • vulva
  • VULVAR INTRAEPITHELIAL NEOPLASIA
  • HUMAN-PAPILLOMAVIRUS TYPE-16
  • SQUAMOUS-CELL CARCINOMA
  • RANDOMIZED CONTROLLED-TRIAL
  • PARTICLE VACCINE
  • SEROUS CARCINOMA
  • MICROSATELLITE INSTABILITY
  • ENDOMETRIAL CARCINOMA
  • LOW-GRADE
  • CERVICAL CARCINOGENESIS

Fingerprint

Dive into the research topics of 'Recent advances in molecular gynaecological pathology'. Together they form a unique fingerprint.

Cite this